GRI Bio (GRI) Current Assets (2020 - 2026)
GRI Bio (GRI) posted quarterly Current Assets of $11.3 million for Q1 2026, up 187.0% year-over-year from $3.9 million in Q1 2025, and up 31.27% quarter-over-quarter from $8.6 million in Q4 2025.
GRI Bio (GRI) Current Assets (2020 - 2026) Analysis & Trends
GRI Bio's Current Assets history runs 7 years deep, the most recent figure standing at $11.3 million for Q1 2026.
- In Q1 2026, Current Assets rose 187.0% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $11.3 million (up 187.0% YoY), while the FY2025 annual figure was $8.6 million, up 53.02% from the prior year.
- Current Assets for Q1 2026 stood at $11.3 million, up from $8.6 million in the prior quarter.
- The five-year high for Current Assets was $11.3 million in Q1 2026, with the low at $312000.0 in Q4 2022.
- The 5-year median for Current Assets is $5.6 million (2022), against an average of $5.5 million.
- The sharpest annual moves came in 2022 and 2023: Current Assets plunged 96.16% in 2022, then soared 840.38% in 2023.
- GRI Bio's Current Assets stood at $312000.0 in 2022, then jumped by 840.38% to $2.9 million in 2023, then surged by 91.38% to $5.6 million in 2024, then surged by 53.02% to $8.6 million in 2025, then soared by 31.27% to $11.3 million in 2026.
- Business Quant data shows GRI's Current Assets at $11.3 million in Q1 2026, $8.6 million in Q4 2025, and $4.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.90 Bn | 132.05 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.73 Bn | 60.55 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.33 Bn | 53.19 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.72 Bn | 28.42 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.88 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.25 Bn | 26.41 Bn | - | 1.76 Bn |
| 10 | GRI Bio | 3.07 Mn | 3.07 Mn | - | 11.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.28 Mn |
| Dec 31, 2025 | 8.59 Mn |
| Sep 30, 2025 | 4.70 Mn |
| Jun 30, 2025 | 5.58 Mn |
| Mar 31, 2025 | 3.93 Mn |
| Dec 31, 2024 | 5.62 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | 4.43 Mn |
| Dec 31, 2023 | 2.93 Mn |
| Sep 30, 2023 | 4.37 Mn |
| Jun 30, 2023 | 5.59 Mn |
| Dec 31, 2022 | 312,000.00 |
| Sep 30, 2022 | 5.57 Mn |
| Jun 30, 2022 | 7.84 Mn |
| Mar 31, 2022 | 5.76 Mn |
| Dec 31, 2021 | 8.13 Mn |
| Sep 30, 2021 | 9.92 Mn |
| Jun 30, 2021 | 11.40 Mn |
| Mar 31, 2021 | 14.34 Mn |